Structure

Physi-Chem Properties

Molecular Weight:  622.17
Volume:  605.165
LogP:  3.116
LogD:  2.113
LogS:  -3.521
# Rotatable Bonds:  12
TPSA:  209.51
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.083
Synthetic Accessibility Score:  4.22
Fsp3:  0.219
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.2
MDCK Permeability:  1.9838320440612733e-05
Pgp-inhibitor:  0.019
Pgp-substrate:  0.099
Human Intestinal Absorption (HIA):  0.538
20% Bioavailability (F20%):  0.945
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.04
Plasma Protein Binding (PPB):  101.61698150634766%
Volume Distribution (VD):  0.48
Pgp-substrate:  0.7412636876106262%

ADMET: Metabolism

CYP1A2-inhibitor:  0.337
CYP1A2-substrate:  0.017
CYP2C19-inhibitor:  0.346
CYP2C19-substrate:  0.051
CYP2C9-inhibitor:  0.716
CYP2C9-substrate:  0.7
CYP2D6-inhibitor:  0.763
CYP2D6-substrate:  0.227
CYP3A4-inhibitor:  0.621
CYP3A4-substrate:  0.19

ADMET: Excretion

Clearance (CL):  5.086
Half-life (T1/2):  0.952

ADMET: Toxicity

hERG Blockers:  0.147
Human Hepatotoxicity (H-HT):  0.165
Drug-inuced Liver Injury (DILI):  0.779
AMES Toxicity:  0.754
Rat Oral Acute Toxicity:  0.302
Maximum Recommended Daily Dose:  0.032
Skin Sensitization:  0.961
Carcinogencity:  0.347
Eye Corrosion:  0.003
Eye Irritation:  0.532
Respiratory Toxicity:  0.026

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC88560

Natural Product ID:  NPC88560
Common Name*:   4'-O-Beta-D-(2''-P-Coumaroyl-6''-Acetyl)Glucopyranosyl-4,2',3'-Trihydroxychalcone
IUPAC Name:   [(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-2-[2,3-dihydroxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]phenoxy]-4,5-dihydroxyoxan-3-yl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  MNTAKHYEMJWPAC-SHVUDZGFSA-N
Standard InCHI:  InChI=1S/C32H30O13/c1-17(33)42-16-25-29(40)30(41)31(45-26(37)15-7-19-4-10-21(35)11-5-19)32(44-25)43-24-14-12-22(27(38)28(24)39)23(36)13-6-18-2-8-20(34)9-3-18/h2-15,25,29-32,34-35,38-41H,16H2,1H3/b13-6+,15-7+/t25-,29-,30+,31-,32-/m1/s1
SMILES:  CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](Oc2ccc(C(=O)/C=C/c3ccc(cc3)O)c(c2O)O)O1)OC(=O)/C=C/c1ccc(cc1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL458446
PubChem CID:   10908299
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. n.a. n.a. PMID[11087602]
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. n.a. n.a. PMID[12932124]
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. stem n.a. PMID[12932124]
NPO27239 Maclura tinctoria Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 1.71 mM PMID[552586]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC88560 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC172033
1.0 High Similarity NPC175230
0.9876 High Similarity NPC204937
0.9876 High Similarity NPC149011
0.9755 High Similarity NPC472993
0.9752 High Similarity NPC116745
0.9639 High Similarity NPC471030
0.9636 High Similarity NPC472991
0.9636 High Similarity NPC472992
0.9583 High Similarity NPC470416
0.9578 High Similarity NPC476623
0.9578 High Similarity NPC477895
0.9578 High Similarity NPC476621
0.9578 High Similarity NPC217520
0.9578 High Similarity NPC476620
0.9578 High Similarity NPC472387
0.9578 High Similarity NPC139571
0.9578 High Similarity NPC476618
0.9578 High Similarity NPC35167
0.9578 High Similarity NPC476619
0.9578 High Similarity NPC476622
0.9573 High Similarity NPC172807
0.9573 High Similarity NPC211594
0.9573 High Similarity NPC67134
0.9573 High Similarity NPC47140
0.9573 High Similarity NPC254540
0.9571 High Similarity NPC229687
0.9565 High Similarity NPC88043
0.9524 High Similarity NPC199172
0.9524 High Similarity NPC36138
0.9524 High Similarity NPC35924
0.9518 High Similarity NPC144097
0.9518 High Similarity NPC61904
0.9515 High Similarity NPC4390
0.9509 High Similarity NPC229729
0.9509 High Similarity NPC45400
0.9506 High Similarity NPC22832
0.9506 High Similarity NPC311830
0.9506 High Similarity NPC165720
0.9503 High Similarity NPC33298
0.9503 High Similarity NPC285108
0.9467 High Similarity NPC470717
0.9467 High Similarity NPC25946
0.9467 High Similarity NPC460984
0.9467 High Similarity NPC470720
0.9467 High Similarity NPC470713
0.9467 High Similarity NPC21359
0.9461 High Similarity NPC293626
0.9461 High Similarity NPC253521
0.9461 High Similarity NPC267680
0.9461 High Similarity NPC267549
0.9461 High Similarity NPC217387
0.9461 High Similarity NPC37668
0.9461 High Similarity NPC196127
0.9461 High Similarity NPC113836
0.9461 High Similarity NPC258044
0.9458 High Similarity NPC223426
0.9458 High Similarity NPC81042
0.9458 High Similarity NPC214621
0.9458 High Similarity NPC34267
0.9458 High Similarity NPC477848
0.9455 High Similarity NPC307518
0.9455 High Similarity NPC190003
0.9455 High Similarity NPC175107
0.9455 High Similarity NPC153755
0.9455 High Similarity NPC48773
0.9455 High Similarity NPC472386
0.9455 High Similarity NPC205076
0.9451 High Similarity NPC186807
0.9451 High Similarity NPC105025
0.9451 High Similarity NPC45638
0.9451 High Similarity NPC469931
0.9451 High Similarity NPC93337
0.9451 High Similarity NPC201292
0.9451 High Similarity NPC226294
0.9451 High Similarity NPC58053
0.9451 High Similarity NPC475942
0.9448 High Similarity NPC236934
0.9448 High Similarity NPC5778
0.9444 High Similarity NPC191306
0.9444 High Similarity NPC270335
0.9444 High Similarity NPC222936
0.9444 High Similarity NPC309025
0.9444 High Similarity NPC88023
0.9444 High Similarity NPC243930
0.9444 High Similarity NPC284960
0.9444 High Similarity NPC168822
0.9444 High Similarity NPC19709
0.9412 High Similarity NPC104910
0.9412 High Similarity NPC473554
0.9412 High Similarity NPC474093
0.9412 High Similarity NPC295625
0.9412 High Similarity NPC470719
0.9408 High Similarity NPC135831
0.9408 High Similarity NPC241781
0.9408 High Similarity NPC297503
0.9408 High Similarity NPC162394
0.9408 High Similarity NPC156785
0.9408 High Similarity NPC97119
0.9408 High Similarity NPC470718
0.9401 High Similarity NPC79736
0.9401 High Similarity NPC67629
0.9401 High Similarity NPC472385
0.9401 High Similarity NPC198324
0.9401 High Similarity NPC154741
0.9401 High Similarity NPC296018
0.9401 High Similarity NPC233994
0.9401 High Similarity NPC211532
0.9394 High Similarity NPC231194
0.9394 High Similarity NPC244776
0.9394 High Similarity NPC34287
0.9394 High Similarity NPC105511
0.9394 High Similarity NPC224462
0.9394 High Similarity NPC44558
0.9394 High Similarity NPC155763
0.9394 High Similarity NPC474434
0.9394 High Similarity NPC471416
0.9394 High Similarity NPC212748
0.9394 High Similarity NPC22195
0.9394 High Similarity NPC206123
0.9394 High Similarity NPC20505
0.9394 High Similarity NPC116864
0.9394 High Similarity NPC51326
0.9394 High Similarity NPC235260
0.9394 High Similarity NPC183357
0.9394 High Similarity NPC21190
0.939 High Similarity NPC45618
0.939 High Similarity NPC58716
0.939 High Similarity NPC146792
0.9383 High Similarity NPC473043
0.9383 High Similarity NPC300537
0.9383 High Similarity NPC77660
0.9383 High Similarity NPC189142
0.9383 High Similarity NPC127782
0.9379 High Similarity NPC203020
0.9379 High Similarity NPC239966
0.9379 High Similarity NPC289346
0.9357 High Similarity NPC475179
0.9353 High Similarity NPC223860
0.9353 High Similarity NPC275977
0.9353 High Similarity NPC249560
0.9353 High Similarity NPC231254
0.9349 High Similarity NPC469371
0.9345 High Similarity NPC120952
0.9345 High Similarity NPC476773
0.9341 High Similarity NPC237435
0.9341 High Similarity NPC115760
0.9341 High Similarity NPC101191
0.9341 High Similarity NPC135277
0.9341 High Similarity NPC210094
0.9341 High Similarity NPC49344
0.9341 High Similarity NPC264735
0.9341 High Similarity NPC43211
0.9337 High Similarity NPC117260
0.9337 High Similarity NPC235575
0.9337 High Similarity NPC476405
0.9333 High Similarity NPC658
0.9333 High Similarity NPC219904
0.9333 High Similarity NPC138927
0.9333 High Similarity NPC183036
0.9333 High Similarity NPC472381
0.9333 High Similarity NPC170675
0.9333 High Similarity NPC209296
0.9333 High Similarity NPC197708
0.9333 High Similarity NPC472383
0.9333 High Similarity NPC195257
0.9333 High Similarity NPC120099
0.9333 High Similarity NPC95855
0.9333 High Similarity NPC225434
0.9333 High Similarity NPC223747
0.9333 High Similarity NPC210042
0.9333 High Similarity NPC203050
0.9333 High Similarity NPC112755
0.9333 High Similarity NPC471457
0.9329 High Similarity NPC115674
0.9329 High Similarity NPC210073
0.9329 High Similarity NPC21100
0.9329 High Similarity NPC197285
0.9325 High Similarity NPC29830
0.9321 High Similarity NPC182045
0.9317 High Similarity NPC160780
0.9317 High Similarity NPC289811
0.9298 High Similarity NPC33083
0.9286 High Similarity NPC472384
0.9286 High Similarity NPC472380
0.9286 High Similarity NPC472382
0.9286 High Similarity NPC268533
0.9281 High Similarity NPC476374
0.9281 High Similarity NPC21666
0.9281 High Similarity NPC236191
0.9281 High Similarity NPC169977
0.9281 High Similarity NPC204693
0.9281 High Similarity NPC45522
0.9281 High Similarity NPC42773
0.9281 High Similarity NPC51774
0.9281 High Similarity NPC24043
0.9281 High Similarity NPC101026
0.9281 High Similarity NPC239549
0.9277 High Similarity NPC72249
0.9277 High Similarity NPC476365

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC88560 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9341 High Similarity NPD4338 Clinical (unspecified phase)
0.9333 High Similarity NPD7054 Approved
0.9277 High Similarity NPD7472 Approved
0.9277 High Similarity NPD7074 Phase 3
0.9273 High Similarity NPD3818 Discontinued
0.9112 High Similarity NPD7808 Phase 3
0.9107 High Similarity NPD6797 Phase 2
0.9074 High Similarity NPD4868 Clinical (unspecified phase)
0.9053 High Similarity NPD7251 Discontinued
0.9036 High Similarity NPD6167 Clinical (unspecified phase)
0.9036 High Similarity NPD6168 Clinical (unspecified phase)
0.9036 High Similarity NPD6166 Phase 2
0.9018 High Similarity NPD4381 Clinical (unspecified phase)
0.8889 High Similarity NPD1934 Approved
0.8772 High Similarity NPD7993 Clinical (unspecified phase)
0.872 High Similarity NPD2801 Approved
0.872 High Similarity NPD2393 Clinical (unspecified phase)
0.8667 High Similarity NPD3817 Phase 2
0.8655 High Similarity NPD7804 Clinical (unspecified phase)
0.8614 High Similarity NPD3882 Suspended
0.8613 High Similarity NPD6559 Discontinued
0.8452 Intermediate Similarity NPD7075 Discontinued
0.8439 Intermediate Similarity NPD5844 Phase 1
0.8424 Intermediate Similarity NPD4380 Phase 2
0.8395 Intermediate Similarity NPD1511 Approved
0.8373 Intermediate Similarity NPD7411 Suspended
0.8363 Intermediate Similarity NPD6232 Discontinued
0.8354 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD5402 Approved
0.8324 Intermediate Similarity NPD7473 Discontinued
0.8305 Intermediate Similarity NPD8313 Approved
0.8305 Intermediate Similarity NPD8312 Approved
0.8303 Intermediate Similarity NPD1653 Approved
0.8295 Intermediate Similarity NPD7685 Pre-registration
0.8293 Intermediate Similarity NPD1512 Approved
0.8287 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD7819 Suspended
0.8274 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD1465 Phase 2
0.8246 Intermediate Similarity NPD5494 Approved
0.8225 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8214 Intermediate Similarity NPD6801 Discontinued
0.8198 Intermediate Similarity NPD7199 Phase 2
0.8171 Intermediate Similarity NPD6799 Approved
0.8171 Intermediate Similarity NPD7228 Approved
0.8161 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD5403 Approved
0.8111 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD1549 Phase 2
0.8081 Intermediate Similarity NPD6234 Discontinued
0.8025 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8021 Intermediate Similarity NPD8151 Discontinued
0.8012 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD5401 Approved
0.8 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD37 Approved
0.7989 Intermediate Similarity NPD6959 Discontinued
0.7966 Intermediate Similarity NPD3751 Discontinued
0.7965 Intermediate Similarity NPD4966 Approved
0.7965 Intermediate Similarity NPD4967 Phase 2
0.7965 Intermediate Similarity NPD7768 Phase 2
0.7965 Intermediate Similarity NPD4965 Approved
0.7952 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD3749 Approved
0.7914 Intermediate Similarity NPD7266 Discontinued
0.7904 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7882 Intermediate Similarity NPD6599 Discontinued
0.7879 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD2796 Approved
0.7849 Intermediate Similarity NPD8455 Phase 2
0.7841 Intermediate Similarity NPD3787 Discontinued
0.7831 Intermediate Similarity NPD6190 Approved
0.7826 Intermediate Similarity NPD1933 Approved
0.7826 Intermediate Similarity NPD230 Phase 1
0.7791 Intermediate Similarity NPD1510 Phase 2
0.776 Intermediate Similarity NPD7435 Discontinued
0.7755 Intermediate Similarity NPD7783 Phase 2
0.7755 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD447 Suspended
0.7711 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD3926 Phase 2
0.7696 Intermediate Similarity NPD6779 Approved
0.7696 Intermediate Similarity NPD6778 Approved
0.7696 Intermediate Similarity NPD6776 Approved
0.7696 Intermediate Similarity NPD6777 Approved
0.7696 Intermediate Similarity NPD6780 Approved
0.7696 Intermediate Similarity NPD6782 Approved
0.7696 Intermediate Similarity NPD6781 Approved
0.7692 Intermediate Similarity NPD7240 Approved
0.767 Intermediate Similarity NPD919 Approved
0.7665 Intermediate Similarity NPD3750 Approved
0.7665 Intermediate Similarity NPD4628 Phase 3
0.7654 Intermediate Similarity NPD1240 Approved
0.7654 Intermediate Similarity NPD943 Approved
0.7654 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD1613 Approved
0.7651 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD1551 Phase 2
0.7632 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7629 Intermediate Similarity NPD7871 Phase 2
0.7629 Intermediate Similarity NPD7870 Phase 2
0.7614 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD7874 Approved
0.7577 Intermediate Similarity NPD7697 Approved
0.7577 Intermediate Similarity NPD7698 Approved
0.7577 Intermediate Similarity NPD7696 Phase 3
0.7561 Intermediate Similarity NPD1607 Approved
0.7551 Intermediate Similarity NPD7584 Approved
0.7531 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD2935 Discontinued
0.7514 Intermediate Similarity NPD3226 Approved
0.7513 Intermediate Similarity NPD7701 Phase 2
0.7487 Intermediate Similarity NPD7680 Approved
0.7487 Intermediate Similarity NPD8150 Discontinued
0.7486 Intermediate Similarity NPD1247 Approved
0.7485 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD2532 Approved
0.7485 Intermediate Similarity NPD2533 Approved
0.7485 Intermediate Similarity NPD2534 Approved
0.7469 Intermediate Similarity NPD3027 Phase 3
0.7449 Intermediate Similarity NPD8320 Phase 1
0.7449 Intermediate Similarity NPD8319 Approved
0.7446 Intermediate Similarity NPD5953 Discontinued
0.7436 Intermediate Similarity NPD6823 Phase 2
0.7435 Intermediate Similarity NPD6534 Approved
0.7435 Intermediate Similarity NPD6535 Approved
0.7414 Intermediate Similarity NPD7458 Discontinued
0.7409 Intermediate Similarity NPD7699 Phase 2
0.7409 Intermediate Similarity NPD7700 Phase 2
0.7407 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD7801 Approved
0.7399 Intermediate Similarity NPD920 Approved
0.7394 Intermediate Similarity NPD8434 Phase 2
0.7371 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD3748 Approved
0.7346 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7585 Approved
0.7337 Intermediate Similarity NPD7286 Phase 2
0.7333 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD5353 Approved
0.7301 Intermediate Similarity NPD6832 Phase 2
0.7293 Intermediate Similarity NPD8127 Discontinued
0.7286 Intermediate Similarity NPD7583 Approved
0.7283 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2346 Discontinued
0.7262 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD2799 Discontinued
0.7239 Intermediate Similarity NPD9494 Approved
0.7222 Intermediate Similarity NPD1203 Approved
0.7219 Intermediate Similarity NPD7038 Approved
0.7219 Intermediate Similarity NPD7039 Approved
0.7213 Intermediate Similarity NPD5242 Approved
0.7212 Intermediate Similarity NPD6798 Discontinued
0.7212 Intermediate Similarity NPD2313 Discontinued
0.7202 Intermediate Similarity NPD6212 Phase 3
0.7202 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD6213 Phase 3
0.7195 Intermediate Similarity NPD4908 Phase 1
0.7193 Intermediate Similarity NPD1243 Approved
0.7193 Intermediate Similarity NPD2800 Approved
0.7193 Intermediate Similarity NPD6674 Discontinued
0.7186 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD2344 Approved
0.7174 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6233 Phase 2
0.7168 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD7033 Discontinued
0.7151 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD9269 Phase 2
0.7135 Intermediate Similarity NPD6386 Approved
0.7135 Intermediate Similarity NPD6385 Approved
0.7126 Intermediate Similarity NPD7390 Discontinued
0.7108 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD6844 Discontinued
0.7095 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD1652 Phase 2
0.709 Intermediate Similarity NPD7549 Discontinued
0.7086 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7085 Intermediate Similarity NPD5005 Approved
0.7085 Intermediate Similarity NPD5006 Approved
0.7081 Intermediate Similarity NPD1091 Approved
0.7065 Intermediate Similarity NPD5710 Approved
0.7065 Intermediate Similarity NPD7229 Phase 3
0.7065 Intermediate Similarity NPD5711 Approved
0.7059 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD4287 Approved
0.7039 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7930 Approved
0.7037 Intermediate Similarity NPD9717 Approved
0.7018 Intermediate Similarity NPD6099 Approved
0.7018 Intermediate Similarity NPD6100 Approved
0.7011 Intermediate Similarity NPD2309 Approved
0.7 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7097 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data